Reidy Christopher R 4

What Happened

• Christopher R. Reidy, a director of Encompass Health Corp (EHC), was granted 1,634 shares via an award (transaction code A) on May 7, 2026.
• The Form 4 reports an acquisition price of $0.00 (typical for restricted stock unit awards). The filing does not state the grant's market value or Reidy’s post-grant total holdings.
• This was an award/grant (not an open-market purchase or sale), so it is not an immediate “buy” signal.

Key Details

• Transaction date: 2026-05-07; Form 4 filed: 2026-05-11 (appears to be within the SEC’s two-business-day filing window).
• Security/count: 1,634 shares (restricted stock units / award).
• Reported acquisition price: $0.00 (award/grant).
• Footnote: Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.
• Post-transaction ownership: Not specified in the provided filing details.
• No 10b5-1 plan, tax-withholding, or gift codes noted in the provided data.

Context

• RSU awards typically vest over time and may be subject to performance or service conditions; they are compensation, not an immediate market purchase.
• Such grants are common for directors and executives as part of long-term incentive programs and do not by themselves indicate buying or selling intent.